ALPS Medical Breakthroughs ETF company info

What does ALPS Medical Breakthroughs ETF do?
ALPS Medical Breakthroughs ETF (NYSE:SBIO) is dedicated to investing in the healthcare sector, focusing on small and medium biotechnology and pharmaceutical companies engaged in the clinical trial stage of drug development. With an emphasis on innovation, the ETF aims to support the progress of medical breakthroughs that have the potential to offer significant advancements in treatments and cures for various conditions. Its projects include a diversified portfolio of companies that are on the forefront of developing novel therapies and medical technologies. The objective of ALPS Medical Breakthroughs ETF is to provide investors with access to the high-growth potential of the biotech and pharma sectors, while also contributing to the advancement of medical science.
ALPS Medical Breakthroughs ETF company media
Company Snapshot

Is ALPS Medical Breakthroughs ETF a public or private company?

key
Ownership
Public

How many people does ALPS Medical Breakthroughs ETF employ?

people
Employees
212

What sector is ALPS Medical Breakthroughs ETF in?

pie chart
Sector
ETF

Where is the head office for ALPS Medical Breakthroughs ETF?

location pin
Head Office
Denver, United States

What year was ALPS Medical Breakthroughs ETF founded?

founded flag
Year Founded
2014
What does ALPS Medical Breakthroughs ETF specialise in?
/Biotechnology Investments /Pharmaceutical Stocks /Innovative Therapies /Growth Potential /Healthcare Research /Emerging Medicine

What are the products and/or services of ALPS Medical Breakthroughs ETF?

Overview of ALPS Medical Breakthroughs ETF offerings
Investment in small-cap and mid-cap companies focused on medical breakthroughs significant for disease treatment, prevention, and cure.
Portfolio diversification across various healthcare sectors including biotechnology and pharmaceuticals aiming at innovative solutions.
Research and analysis services providing insights into the biopharmaceutical industry, identifying companies with potential for significant growth.
Financial support and capital investment in companies with promising medical and healthcare advancements, fostering industry innovation.
Educational resources and tools for investors interested in the medical breakthroughs sector, promoting informed investment decisions.
Outreach and partnership programs with healthcare institutions and research organizations to identify and support emerging medical technologies.